The stock of LifeStance Health Group Inc (LFST) has gone up by 4.48% for the week, with a 4.90% rise in the past month and a 12.90% rise in the past quarter. The volatility ratio for the week is 4.11%, and the volatility levels for the past 30 days are 4.25% for LFST.. The simple moving average for the past 20 days is 4.10% for LFST’s stock, with a 19.73% simple moving average for the past 200 days.
Is It Worth Investing in LifeStance Health Group Inc (NASDAQ: LFST) Right Now?
The 36-month beta value for LFST is also noteworthy at 1.26. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for LFST is 111.01M, and at present, short sellers hold a 9.88% of that float. The average trading volume of LFST on January 10, 2025 was 1.47M shares.
LFST) stock’s latest price update
LifeStance Health Group Inc (NASDAQ: LFST) has experienced a rise in its stock price by 2.39 compared to its previous closing price of 7.52. However, the company has seen a gain of 4.48% in its stock price over the last five trading days. https://thefly.com reported 2024-12-16 that Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Tenet, the analyst sees policy risk “taking center stage” and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock’s valuation.
Analysts’ Opinion of LFST
Many brokerage firms have already submitted their reports for LFST stocks, with Goldman repeating the rating for LFST by listing it as a “Buy.” The predicted price for LFST in the upcoming period, according to Goldman is $10 based on the research report published on December 16, 2024 of the previous year 2024.
Barclays, on the other hand, stated in their research note that they expect to see LFST reach a price target of $7. The rating they have provided for LFST stocks is “Underweight” according to the report published on January 03rd, 2024.
TD Cowen gave a rating of “Market Perform” to LFST, setting the target price at $9 in the report published on May 15th of the previous year.
LFST Trading at 5.56% from the 50-Day Moving Average
After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.30% of loss for the given period.
Volatility was left at 4.25%, however, over the last 30 days, the volatility rate increased by 4.11%, as shares surge +3.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.41% upper at present.
During the last 5 trading sessions, LFST rose by +4.48%, which changed the moving average for the period of 200-days by +29.85% in comparison to the 20-day moving average, which settled at $7.40. In addition, LifeStance Health Group Inc saw 4.48% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFST starting from Bessler Robert, who sale 75,000 shares at the price of $7.54 back on Nov 27 ’24. After this action, Bessler Robert now owns 1,424,447 shares of LifeStance Health Group Inc, valued at $565,500 using the latest closing price.
Bessler Robert, the Director of LifeStance Health Group Inc, proposed sale 75,000 shares at $7.54 during a trade that took place back on Nov 27 ’24, which means that Bessler Robert is holding shares at $565,646 based on the most recent closing price.
Stock Fundamentals for LFST
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.26 for the gross margin
The net margin for LifeStance Health Group Inc stands at -0.08. The total capital return value is set at -0.03. Equity return is now at value -6.59, with -4.45 for asset returns.
Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is -2.8.
Currently, EBITDA for the company is -104.93 million with net debt to EBITDA at 27.21. When we switch over and look at the enterprise to sales, we see a ratio of 2.76. The receivables turnover for the company is 7.63for trailing twelve months and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.32.
Conclusion
In summary, LifeStance Health Group Inc (LFST) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
